David Harris
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hematology top 1%
- Acute Myeloid Leukemia Research
Papers in
- Genetics 39
- Chronic Lymphocytic Leukemia Research 34
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Hematology 33
- Acute Myeloid Leukemia Research 27
- Platelet Disorders and Treatments 3
- Co-authors
- Zeev E. Estrov (78 shared papers)Michael Andreeff (12 shared papers)Hagop M. Kantarjian (19 shared papers)Marina Y Konopleva (10 shared papers)Quin Van (22 shared papers)Moshe Talpaz (16 shared papers)Alessandra Ferrajoli (34 shared papers)Stefan H Faderl (20 shared papers)
- Journals
- Blood (30 papers)Cancer Research (5 papers)Molecular Cancer Research (4 papers)PLoS ONE (4 papers)Journal of Clinical Investigation (3 papers)
- Partner nations
- United StatesIsraelFinland
In The Last Decade
David Harris
84 papers receiving 5.2k citations
David Harris's Hit Papers
Peers
Comparison fields: 5 of 96
- Genetics 885
- Hematology 1.1k
- Geriatrics and Gerontology 113
- Molecular Biology 1.8k
- Oncology 634
Countries citing papers authored by David Harris
This map shows the geographic impact of David Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Harris more than expected).
Fields of papers citing papers by David Harris
This network shows the impact of papers produced by David Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Harris. The network helps show where David Harris may publish in the future.
Co-authors
The 25 scholars most cited alongside David Harris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia Hit paper breakdown → | 2006 | 901 |
| 2 | 2008 | 309 | |
| 3 | 2001 | 282 | |
| 4 | 2003 | 270 | |
| 5 | 2008 | 230 | |
| 6 | 2013 | 183 | |
| 7 | 2010 | 172 | |
| 8 | 2006 | 161 | |
| 9 | 1999 | 160 | |
| 10 | 1998 | 130 | |
| 11 | 2016 | 129 | |
| 12 | 2007 | 119 | |
| 13 | 2005 | 118 | |
| 14 | 2002 | 111 | |
| 15 | 2017 | 108 | |
| 16 | 2000 | 103 | |
| 17 | 2006 | 93 | |
| 18 | 2005 | 90 | |
| 19 | 1996 | 83 | |
| 20 | 2006 | 77 |
About David Harris
David Harris is a scholar working on Genetics, Hematology, Cancer Research, Molecular Biology and Immunology and Allergy, having authored 85 papers that have together received 5.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (34 papers), Acute Myeloid Leukemia Research (27 papers), Cell death mechanisms and regulation (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Acute Lymphoblastic Leukemia research (4 papers), MicroRNA in disease regulation (3 papers), Platelet Disorders and Treatments (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (885 citations), Hematology (1.1k citations), Geriatrics and Gerontology (113 citations), Molecular Biology (1.8k citations) and Oncology (634 citations). David Harris has collaborated with scholars based in United States, Israel and Finland. Frequent co-authors include Zeev E. Estrov, Michael Andreeff, Hagop M. Kantarjian, Marina Y Konopleva, Quin Van, Moshe Talpaz, Alessandra Ferrajoli, Stefan H Faderl, Michael J. Keating and Ping Li. Their work appears in journals such as Blood, Cancer Research, Molecular Cancer Research, PLoS ONE and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.